| 摘要: |
| 目的 基于驱动蛋白家族 3A 基因(Kif3a)和 Sonic hedgehog(SHH)信号通路探讨洋甘菊活性组分对脂多糖(LPS)诱导的人支气管上皮细胞(16HBE)的保护作用及机制。方法 用LPS诱导16HBE建立哮喘炎症细胞模型。CCK-8法检测不同浓度洋甘菊活性组分对LPS诱导16HBE的增殖的抑制作用,筛选出最佳洋甘菊活性组分给药浓度。将细胞分为空白对照组、LPS模型组、阳性药物组(1 µmol•L-1地塞米松干预2 h)、洋甘菊活性组分组(200 µg•mL-1,48 h)。Annexin V/PI结合流式细胞术检测各组的凋亡率。实时荧光PCR法和Western blot法检测Kif3a、SHH、Ptch1和Gli1的mRNA和蛋白表达变化。结果 LPS干预后,可显著降低16HBE活力(P < 0.05),并诱导其细胞凋亡(P < 0.01)。洋甘菊活性组分在浓度200 µg•mL-1处理48 h时,可以显著逆转LPS对细胞的损伤并促进增殖(P < 0.01),减弱LPS诱导的细胞凋亡(P< 0.01)。与空白对照组比较,LPS诱导的16HBE内Kif3a在mRNA水平和蛋白表达水平显著降低(P < 0.05),SHH、Ptch1、Gli1在mRNA水平和蛋白表达水平显著升高(P < 0.05);与LPS模型组相比较,洋甘菊活性组分处理后可显著逆转mRNA水平和蛋白表达(P< 0.05),增加Kif3a的mRNA水平和蛋白表达水平,并降低SHH、Ptch1、Gli1的mRNA水平和蛋白表达(P< 0.05)。结论 LPS诱导16HBE损伤,下调Kif3a水平从而上调SHH、Ptch1、Gli1水平,调控SHH信号通路处于异常激活状态。洋甘菊活性组分可显著逆转LPS诱导的细胞炎症损伤,上调Kif3a水平,下调SHH、Ptch1、Gli1水平,通过Kif3a调控SHH信号通路,对LPS诱导的16HBE发挥保护作用,改善哮喘气道炎症。 |
| 关键词: 洋甘菊活性组分 哮喘 人支气管上皮细胞 Kif3a SHH信号通路 |
| DOI:10.13506/j.cnki.jpr.2023.05.002 |
| 基金项目:新疆维吾尔自治区自然科学基金-杰出青年科学基金(No.2021D01E32);乌鲁木齐市科学技术局优秀青年科技人才培养项目 |
|
Publication Date:May 25, 2023
|
|
| The protective effect and mechanism of the active components of Matricaria chamomilla L. on LPS-induced human bronchial epithelial cells |
| NADIRE·Aierken1,2,PENG Jun1,2,3,FAN Fangfang1,2,LI Qian1,2 |
| (1. Department of Pharmacy, Fourth Clinical College of Xinjiang Medical University, Urumqi 830000, China;2. Xinjiang Key Laboratory of Processing and Research of Traditional Chinese Medicine, Urumqi 830000, China;3. Key Laboratory of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830000,China) |
| Abstract: |
| Objective To investigate the protective effect and mechanism of the active components of Matricaria chamomilla L. on LPS-induced (lipopolysaccharide) human bronchial epithelial cells (16HBE) based on Kif3a and SHH signaling pathway.Methods LPS-induced 16HBE were established as the asthma inflammatory cell model, CCK-8 assay was used to detect the inhibitory effect of the active components of M. chamomile on 16HBE induced by LPS at different concentrations, and the optimal concentration of the active components of M. chamomile was selected. The cells were divided into normal control group, LPS model group, positive drug group (1 µmol•L-1 dexamethasone intervention for 2 h), and the active components of M. chamomile group (200 µg•mL-1, 48 h). Cell apoptosis rate was analyzed by Annexin V/PI staining and flow cytometry. mRNA and protein expression of Kif3a, SHH, Ptch1 and Glil were evaluated by real-time PCR and Western Blot, respectively.Results After LPS intervention, 16HBE cell viability was reduced (P<0.05) and apoptosis was induced (P<0.01), significantly. The active components of M. chamomile at 200 µg•mL-1 for 48 h can reverse the damage of 16HBE induced by LPS, increased cells proliferative activity (P < 0.01) and reduced LPS-induced apoptosis (P < 0.01), significantly. Compared with normal control group, the mRNA level and protein expression level of Kif3a in 16HBE induced by LPS were decreased (P < 0.05), and the mRNA level and protein expression level of SHH, Ptc1 and Gli1 were significantly increased (P<0.05); Compared with LPS model group, the active components of M. chamomile group can significantly reverse LPS-induced cells damage, increase Kif3a mRNA level and protein expression level (P0.05), and reduce SHH, Ptch1, Gli1 mRNA level and protein expression (P < 0.05). Conclusion LPS induced the injury in 16HBE, down-regulated the level of Kif3a and up-regulated the levels of SHH, Ptch 1 and Gli1, which makes the SHH signaling pathway in an abnormal state of activation. The active components of M. chamomile can significantly reverse the LPS-induced cell damage, up-regulate the level of Kif3a, and down-regulate the level of SHH, Ptch1, and Gli1. It can regulate the SHH signaling pathway through Kif3a to play a protective role on LPS-induced 16HBE and improve asthma airway inflammation. |
| Key words: The active components of Matricaria chamomilla L. Asthma Human bronchial epithelial cells Kif3a SHH signaling pathway |